Psychedelics Archives - Page 66 of 68

2 minute read

Will This Cannabis Company Also Become A Psilocybin Producer And Facilitator? Here’s What They’re Thinking

August 3, 3:03 PM

Kaya Holdings Inc., (OTCQB: KAYS), also known as “KAYS,” holder and operator of U.S cannabis licenses in all plant-touching categories, initiated the process of seeking the requisite licenses to manufacture psilocybin and set up facilitation service centers in Oregon

KAYS

1 minute read

Small Pharma: New Canadian Patent For Proprietary DMT Analogue, Adds To Growing International Protection Grants

By Lara Goldstein

August 3, 2:56 PM

Biotech producer of short-acting psychedelics for therapeutic purposes Small Pharma Inc.

DMTTF

4 minute read

Telehealth Market News: Braxia Scientific Enters Industry By Acquiring Ketamine Treatment Platform In Florida

By Lara Goldstein

August 3, 2:52 PM

A researcher and provider of ketamine-assisted treatments for mental health conditions, Braxia Scientific Corp.

BRAXF

2 minute read

Red Light Holland Closes 2022 Fiscal Year, Shares Financial And Business Results

By Lara Goldstein

August 2, 1:59 PM

Red Light Holland Corp.

TRUFF

1 minute read

Learn About HAVN Life’s New Shares Consolidation, What Changes And What Remains

By Lara Goldstein

August 1, 3:47 PM

A key player in the biotech-meets-psychedelics space, HAVN Life Sciences Inc.

HAVLF

2 minute read

Morgan Stanley Reports On Psychedelics: A Potential Long-Term Investment Portfolio For An Emerging Market

By Lara Goldstein

August 1, 3:17 PM

Counterpoint Global is Morgan Stanley’s (NYSE: MS) Investment Management division in charge of understanding new or “disruptive” market opportunities that hold “the potential to trigger far-reaching consequences” and therefore constitute a likely sound, long-term i

3 minute read

Science Feature: Next-Generation Psychedelics

By Microdose Psychedelic Insights

July 31, 12:55 PM

This article was originally published on Microdose and appears here with permission.

CYBN

2 minute read

Hemp Company Offers Ketamine-Assisted Therapy To Employees As A Healthcare Benefit

By Lara Goldstein

July 28, 3:57 PM

Plant-based wellness product provider HempLucid is advancing medically supervised ketamine-assisted therapy (KAP) as an employee healthcare benefit.

TSX:NUMI

2 minute read

Canada-Based Project Solace Aims To Provide Access And Data On Medical Psilocybin

By Lara Goldstein

July 28, 10:04 AM

TheraPsil, a Canadian coalition for psilocybin therapy legalization, together with the U.K. independent foundation Drug Science, has launched Project Solace.

FLHLF

2 minute read

EXCLUSIVE: Psychedelics-Assisted Psychotherapy Co. Bienstar Adds Renown Psychiatrist Dartiu Da Silveira As Scientific Advisor

By Javier Hasse

July 27, 2:42 PM

Zinger Brief Dr. Dartiu da Silveira is a renowned Brazilian psychiatrist and a pioneer in psychedelics scientific research. Dr. Silveira will collaborate with Bienstar as a scientific advisor. The advisor will focus on ibogaine assisted therapies protocols, medical education programs and clinical research development.

NUMIF